US Patent Issued to AbelZeta on Oct. 21 for "Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,432, issued on Oct. 21, was assigned to AbelZeta Inc. (Rockville, Md.).

"Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof" was invented by Yihong Yao (Rockville, Md.), Yanfeng Li (Hong Kong), Yutian Wei (Hong Kong), Shigui Zhu (Rockville, Md.), Xin Yao (Rockville, Md.) and Jiaqi Huang (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a combined chimeric antigen receptor targeting CD19 and CD20 and application thereof. Specifically, the present invention provides a combined chimeric antigen receptor targeting CD19 and CD20, which comprises a scFv targeting CD19 and CD20, a ...